Literature DB >> 33868964

D-Dimer and Serum ferritin as an Independent Risk Factor for Severity in COVID-19 Patients.

Ali M Hussein1, Zhala B Taha2, Ahmed Gailan Malek1, Kamgar Akram Rasul1, Dur Hazim Kasim1, Reman Jalal Ahmed1, Usama Badraden Mohamed1.   

Abstract

Ferritin is an intracellular blood protein that contains iron, covid-19 diseases is an infectious disease caused by a virus called corona virus, the infected person mostly experiences mild to moderate respiratory illness ferritin level in blood mostly depend on severity of the covid-19 disease. Ferritin level could be used as an indicator for the covid-19 disease. Within 120 corona virus patients that used as individual in this study, the ferritin level in the blood were tested, also each of (D-Dimer, ESR, C.R protein) Depend on the results, the patients with over 60 years have a high ferritin level also the d-dimer were abnormal with 65% higher than normal range.
© 2021 Elsevier Ltd. All rights reserved. Selection and peer-review under responsibility of the scientific committee of the Emerging Trends in Materials Science, Technology and Engineering.

Entities:  

Keywords:  COVID-19 Patients; D-Dimer; Serum ferritin

Year:  2021        PMID: 33868964      PMCID: PMC8043615          DOI: 10.1016/j.matpr.2021.04.009

Source DB:  PubMed          Journal:  Mater Today Proc        ISSN: 2214-7853


Introduction

The body contains iron in the form of ferritin, which is an intracellular protein composed of 24 subunits circling an iron core containing 4000–4500 iron atoms [1]. Ferritin is an intracellular protein composed of 24 subunits surrounding an iron core containing 4000–4500 iron atoms. Ferritin is a mediator for immune dysregulation, especially in hyper-ferritinemia, with direct immune suppressive and pro-inflammatory effects that cause cytokine storms [2]. The cytokine storm syndrome causes dangerous outcomes in covid-19 disease and the prevalence of the symptoms is depending on the cytokine cloud syndrome [3]. Ferritin levels in blood are common in stable individuals between the ages of 3 months and 16 years (20–200 ng/mL) between the ages of 20 and 60 years (13–150 ng/mL) and between the ages of 20 and 60 years (30–400 ng/mL). Covid-19 disease is an infectious disease that has been declared a global public health emergency by the World Health Organization, with over 3.500.000 cases and 243.043 deaths reported globally almost since inception in Wuhan China. The bulk of covid-19 disease patients had asymptomatic or mild influenza-like illness [4]. Serum ferritin levels are closely linked to the incidence of covid-19 disease [5]. Treatment with iron chelators is one potential method for lowering serum ferritin levels in the body. Deferoxamine medication may also be used because it is a non-toxic iron chelator that has been approved by the FDA and has an effect on long-term iron chelation therapy [6]. Manipulation of serum ferritin levels may be used to reduce nutritional iron [7], [8].

Methodology

Ferritin is identified as prognostic and predictive marker for liver injury [9]. The fight against covid-19 pandemic, attention to ferritin is increasing as risk factor for prognosis of covid-19 . The ferritin is abnormal with the severity of covid-19 disease, but its value remains to be explored [10], [12]. According to the diagnosis and the treatment of novel corona virus with these symptoms, Breath shortness, Oxygen saturation below than 93% and arterial partial pressure of oxygen. Liver injury patients could have elevated levels of aspartate aminotransferase, and alanine transaminase [11], [13]. The samples for the ferritin blood test is a venipuncture samples. The date of beginning points of viral clearance is called admission date, and the date of ending point of viral clearance is called negative detection of covid-19 RNA [14] (Fig. 1 . Fig. 2 ).
Fig. 1

Shows Ferritin levels with in correlations with gender and age.

Fig. 2

Shows Ferritin, ESR, C. R Protein, and D. Dimer levels.

Shows Ferritin levels with in correlations with gender and age. Shows Ferritin, ESR, C. R Protein, and D. Dimer levels.

Results

Statistical programs used for analyzing the results with p < 0.05, the following data were collected and arranged in different figures. Level of ferritin changed with the age of the patients, also (ESR, D-Dimer, Ferritin, C.R protein) showed different levels in comparison with the control group that was the normal range. In first group patients (20–40 years’ male) the ferritin was 50% more than 400 which is the normal range. Patients of the second group (20–40 years’ female) the ferritin was 15.38% more than 150 which is normal range. In third group (40–60 years’ male) the ferritin was 80% more than 400 which is normal range. The fourth group (40–60 years’ female) the ferritin was 80% more than 150 which is normal range. In fifth group (60–80 years’ male) the ferritin was 100% more than 400 which is normal range. In the first test between (30–55 years’ male & female) the ferritin was (575.815) more than 350 which is normal range. The second test between (30–55 years’ male & female) the ESR was 35.5 over than 30 which is normal range. The third test between (30–55 years’ male & female) the C.R Protein was 12 more than 10 which is normal range. The fourth test between (30–55 years’ male & female) was 1.55 more than 0.5 which is normal range.

Discussion

The blood sample was drawn in 101 infected patients with Covid-19 disease, ferritin levels in the blood depend on the severity of the infection on the patient for study data of 101 patients that infected with covid-19 disease were analyzed the elevated range and normal range of ferritin in the patients labelled and matched. When compared to ferritin, which may serve as an easy-to-use predictor for covid-19 disorder, the model combination did not offer a positive prediction on infection incidence or liver damage [15]. Ferritin can serve as a marker for liver damage, serious illness, and course of treatment. Ferritin is an acute phase protein which can be discharged from destroyed hepatocytes [10], [16], [17]. Extra ferritinemia may be caused by impaired liver activity or a metabolic syndrome [18]. Covid-19 patients with abnormal ferritin levels has more risk of liver injury and severe illness, previous studies also found that liver injury is common in covid-19 patients [19], [20], [21]. Summary of these observations is indicative of the fact that early analysis of ferritin can efficiently have recognized liver damage, catastrophic disease, and prognosis of covid-19 patients. Patients with unusual ferritin level should be considered [10], [22].

Conclusion

The Blood parameter shows that the ferritin level will increase in second week after affecting with Covid-19, also other parameters will be changed according to the normal range, such as D-Dimer, ESR, C.R protein. Depend on our case study, these levels will be change because they got Paracetamol vial 500 ml daily twice in hospital that affect the liver function.

CRediT authorship contribution statement

Ali M. Hussein: Conceptualization, Methodology. Zhala B. Taha: Writing - original draft. Ahmed Gailan Malek: Software, Investigation. Kamgar Akram Rasul: Writing - review & editing. Dur Hazim Kasim: Visualization. Reman Jalal Ahmed: Data curation. Usama Badraden Mohamed: Supervision.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  19 in total

1.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Kris V Kowdley; Patricia Belt; Laura A Wilson; Matthew M Yeh; Brent A Neuschwander-Tetri; Naga Chalasani; Arun J Sanyal; James E Nelson
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

2.  Interpreting raised serum ferritin levels.

Authors:  Marianna Koperdanova; Jonathan O Cullis
Journal:  BMJ       Date:  2015-08-03

Review 3.  Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons.

Authors:  Paola Trombini; Alberto Piperno
Journal:  J Hepatol       Date:  2007-01-26       Impact factor: 25.083

4.  Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort.

Authors:  Diana J Fleming; Katherine L Tucker; Paul F Jacques; Gerard E Dallal; Peter W F Wilson; Richard J Wood
Journal:  Am J Clin Nutr       Date:  2002-12       Impact factor: 7.045

5.  The Preventative Effects of Procyanidin on Binge Ethanol-Induced Lipid Accumulation and ROS Overproduction via the Promotion of Hepatic Autophagy.

Authors:  Peng Cao; Yu Zhang; Zi Huang; Mitchell A Sullivan; Zihao He; Jinglin Wang; Zehong Chen; Huiping Hu; Kaiping Wang
Journal:  Mol Nutr Food Res       Date:  2019-07-31       Impact factor: 5.914

Review 6.  A Review on Iron Chelators in Treatment of Iron Overload Syndromes.

Authors:  Naser Mobarra; Mehrnoosh Shanaki; Hassan Ehteram; Hajar Nasiri; Mehdi Sahmani; Mohsen Saeidi; Mehdi Goudarzi; Hoda Pourkarim; Mehdi Azad
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01

7.  Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.

Authors:  Daniel B Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-02-28       Impact factor: 17.586

8.  Liver injury in COVID-19: management and challenges.

Authors:  Chao Zhang; Lei Shi; Fu-Sheng Wang
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-04

9.  Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.

Authors:  Xi Jin; Jiang-Shan Lian; Jian-Hua Hu; Jianguo Gao; Lin Zheng; Yi-Min Zhang; Shao-Rui Hao; Hong-Yu Jia; Huan Cai; Xiao-Li Zhang; Guo-Dong Yu; Kai-Jin Xu; Xiao-Yan Wang; Jue-Qing Gu; Shan-Yan Zhang; Chan-Yuan Ye; Ci-Liang Jin; Ying-Feng Lu; Xia Yu; Xiao-Peng Yu; Jian-Rong Huang; Kang-Li Xu; Qin Ni; Cheng-Bo Yu; Biao Zhu; Yong-Tao Li; Jun Liu; Hong Zhao; Xuan Zhang; Liang Yu; Yong-Zheng Guo; Jun-Wei Su; Jing-Jing Tao; Guan-Jing Lang; Xiao-Xin Wu; Wen-Rui Wu; Ting-Ting Qv; Dai-Rong Xiang; Ping Yi; Ding Shi; Yanfei Chen; Yue Ren; Yun-Qing Qiu; Lan-Juan Li; Jifang Sheng; Yida Yang
Journal:  Gut       Date:  2020-03-24       Impact factor: 23.059

10.  Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.

Authors:  Hansheng Xie; Jianming Zhao; Ningfang Lian; Su Lin; Qunfang Xie; Huichang Zhuo
Journal:  Liver Int       Date:  2020-04-12       Impact factor: 8.754

View more
  6 in total

1.  The Impact of Vaccination Against SARS-CoV-2 Virus on the Outcome of COVID-19 Disease.

Authors:  Dania M AlKhafaji; Reem J Al Argan; Salma AlBahrani; Abrar J Alwaheed; Safi G Alqatari; Abdulmohsen H Al Elq; Waleed Albaker; Marwan Alwazzeh; Amal S AlSulaiman; Reem S AlSulaiman; Hussain M Almadan; Ali A Alhammad; Ali N Almajid; Fatimah H Hakami; Wafa K Alanazi
Journal:  Infect Drug Resist       Date:  2022-07-02       Impact factor: 4.177

2.  Implications of SARS-CoV-2 infection on the clinical, hematological, and inflammatory parameters in COVID-19 patients: A retrospective cross-sectional study.

Authors:  Laila A Damiati; Sami Bahlas; Ahmed Aljohaney; Yasser Bawazir; Mohammad Mustafa; Iuliana Denetiu; Peter N Pushparaj
Journal:  J Infect Public Health       Date:  2022-01-06       Impact factor: 3.718

3.  Identifying SARS-CoV-2 Lineage Mutation Hallmarks and Correlating Them With Clinical Outcomes in Egypt: A Pilot Study.

Authors:  Sara H A Agwa; Hesham Elghazaly; Mahmoud Shawky El Meteini; Yahia A Yahia; Radwa Khaled; Aya M Abd Elsamee; Reham M Darwish; Shaimaa M Elsayed; Hala Hafez; Basma S Mahmoud; Fouda Em; Marwa Matboli
Journal:  Front Mol Biosci       Date:  2022-03-08

4.  Comparison between clinical characteristics and laboratory findings among patients with complicated and noncomplicated SARS-CoV-2 infection: A single-center experience from Shebin Al-Kom, Egypt.

Authors:  Walaa A Fadda; Manal A Al-Batanony; Reham E E Aboukhalil; Heba F Khader; Osamah Al Rugaie
Journal:  Immun Inflamm Dis       Date:  2022-08

5.  Clinico-epidemiological profile and outcomes of adults with COVID-19: A hospital-based retrospective study in Kerala, India.

Authors:  Marthanda Pillai Anand; G K Mini; Moses W Bobby; Asokan Anilkumar; S Kamala; Lr Mohammed Kutty; S Harikrishnan; Jinbert A Lordson; Shaffi Fazaludeen Koya; Sachin Chandran; Grace A Chitra; S S Lal; K R Nayar; A Marthanda Pillai
Journal:  J Family Med Prim Care       Date:  2022-06-30

6.  Spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema in non-ventilated COVID-19 patients.

Authors:  Shadi Hamouri; Mohammad AlQudah; Omar Albawaih; Nabil Al-Zoubi; Sebawe Syaj
Journal:  Future Sci OA       Date:  2021-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.